Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Halsey Drug Company, Inc. (OTC BB:HDGC.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider | Financials
Location
695 North Perryville Road
Crimson Building No. 2
Rockford, IL 61107
Phone: (815) 399-2060
Fax: (815) 399-9710
Email: investor@halseydrug.com
Employees (last reported count): 110
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 37%
·Institutional: 1% (2% of float)
(2 institutions)
·Net Inst. Buying: 69.0K shares (+30.27%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Halsey Drug Company, Inc. and its subsidiaries are engaged in the development, manufacture, sale, and distribution of generic drugs and active pharmaceutical ingredients (APIs). Through its strategic alliance with Watson Pharmaceuticals, the Company sells its generic drug products under the Watson name for distribution by Watson to drugstore chains and drug wholesalers. APIs, also known as bulk chemical products, are used in the development and manufacture of finished dosage pharmaceutical products. The development and sale of APIs generally is not subject to the same level of regulation as is the development and sale of finished dosage products. As a result, APIs may be brought to market substantially sooner than finished dosage products.
More from Market Guide: Expanded Business Description

Financial Summary
Halsey Drug Company is engaged in the manufacture, sale and distribution of generic drugs. The Company has manufactured and sold a broad range of prescription and over-the-counter drug products. For the three months ended 3/31/01 revenues totalled $8 million up from $3.2 million. Net loss fell 97% to $106 thousand. Results reflect the sale of certain product rights to Watson Pharmaceuticals, Inc. Lower loss also reflects increased gross margins.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 1,962; after tax earnings were -4,596. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Michael Reicher, 54
Chairman, CEO
$175K
Gerald Price, 53
Pres, COO, Director
50K
James Emigh, 45
VP-Operations
125K
Peter Clemens, 48
VP, CFO
140K
Phyllis Lambridis, 39
VP of corporate compliance
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:HDGC.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 27-Sep-2000
$0.375
Recent Price$2.41 
52-Week High
on 13-July-2001
$3.45 
Beta0.29 
Daily Volume (3-month avg)57.2K
Daily Volume (10-day avg)33.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+141.0%
52-Week Change
relative to S&P500
+223.3%
Share-Related Items
Market Capitalization$36.1M
Shares Outstanding15.0M
Float9.40M
Dividends & Splits
Annual Dividendnone 
Last Split: 5 for 1 on 20-Feb-1986
Per-Share Data
Book Value (mrq*)-$3.57 
Earnings (ttm)-$0.90 
Earnings (mrq)-$0.30 
Sales (ttm)$1.21 
Cash (mrq*)$0.08 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)1.99 
Income Statements
Sales (ttm)$17.9M
EBITDA (ttm*)$598.0K
Income available to common (ttm)-$13.2M
Profitability
Profit Margin (ttm)-73.7%
Operating Margin (ttm)-10.3%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-77.73%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq*)1.02 
Debt/EquityN/A 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2000
Shares Short102.0K
Percent of Float11.3%
Shares Short
(Prior Month)
102.0K
Short Ratio2.76 
Daily Volume37.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.